The WACC of Trillium Therapeutics Inc (TRIL.TO) is 9.6%.
| Range | Selected | |
| Cost of equity | 12.10% - 16.40% | 14.25% |
| Tax rate | 0.10% - 0.10% | 0.10% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 8.6% - 10.7% | 9.6% |
| Category | Low | High |
| Long-term bond rate | 3.4% | 3.9% |
| Equity market risk premium | 4.7% | 5.7% |
| Adjusted beta | 1.85 | 2.1 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 12.10% | 16.40% |
| Tax rate | 0.10% | 0.10% |
| Debt/Equity ratio | 1 | 1 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 8.6% | 10.7% |
| Selected WACC | 9.6% | |